← Evidence map

ArticleTranslational cancer research2026

Too much, too soon?-trastuzumab deruxtecan in the first line metastatic setting.

Ashley P Davenport et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 42180879